Teladoc
As I predicted in my recent "Telehealth Masquerade" review, the telehealth industry, as we know it, is collapsing. It's a natural selection process, where companies with zero innovation and poor management, such as Teladoc and Amwell, are yielding way to those who already have telehealth as part of their integrated solution: Doximity, Privia, Curai, and - the drum roll - your neighborhood EHR.
Teladoc has just reported earnings. It's bad. The CEO blamed "the macro-economic environment". Really? At a rare time when we have the coveted three "3s": 3.3% real GDP growth, 3.1% inflation rate, 3.7% unemployment rate. Teladoc's management has no one to blame but themselves.
In the latest edition of "AI Health Uncut", I'm taking a deep dive into the disappearance of the telehealth industry as we know it, as well as Teladoc disastrous decision to acquire Livongo via the leveraged buyout (LBO), a move spurred by the venture capital industry with 7wireVentures at the helm.
It is no surprise this has occured. The decreased necessity for social distancing with the conclusion of the covid19 pandemic as well as reduced and unlimited funding for conferencing has inevitably created this situation.
No comments:
Post a Comment